Medirom Files 6-K Announcing Dec 2023 KPI Press Release
Ticker: MRM · Form: 6-K · Filed: Jan 25, 2024 · CIK: 1819704
Complexity: simple
Sentiment: neutral
Topics: KPIs, press-release, operational-update
TL;DR
**Medirom just announced a press release for December 2023 KPIs; check Exhibit 99.1 for the actual numbers!**
AI Summary
On January 25, 2024, Medirom Healthcare Technologies Inc. filed a 6-K announcing the issuance of a press release detailing its Key Performance Indicators (KPIs) for December 2023. While the filing itself doesn't contain the specific KPI data, it signals that investors should look for the separate press release (Exhibit 99.1) to understand the company's recent operational performance. This matters because KPIs provide insight into the health and growth of Medirom's core business, directly impacting investor sentiment and stock valuation.
Why It Matters
This filing alerts investors to the release of crucial operational data for December 2023, which will inform their assessment of Medirom's recent business performance and future prospects.
Risk Assessment
Risk Level: low — This filing is purely administrative, announcing the release of a press release, and does not contain any direct financial risks or opportunities itself.
Analyst Insight
A smart investor would immediately locate and review Exhibit 99.1 (the press release) to analyze the specific December 2023 KPI data, as this information is critical for evaluating the company's recent operational performance and making informed investment decisions.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — the registrant filing the 6-K
- Fumitoshi Fujiwara (person) — Chief Financial Officer who signed the 6-K
- December 2023 (date) — the period for which KPIs are being reported
- January 25, 2024 (date) — the date the 6-K was filed and the press release was issued
FAQ
What is the purpose of this 6-K filing by Medirom Healthcare Technologies Inc.?
The 6-K filing, dated January 25, 2024, serves to announce that Medirom Healthcare Technologies Inc. has issued a press release updating its major Key Performance Indicators (KPIs) for the month of December 2023.
Where can investors find the actual Key Performance Indicator data mentioned in this filing?
The actual Key Performance Indicator data is contained within the press release, which is furnished as Exhibit 99.1 to this 6-K report.
Who signed this 6-K filing on behalf of Medirom Healthcare Technologies Inc. and what is their title?
The 6-K filing was signed by Fumitoshi Fujiwara, who holds the title of Chief Financial Officer for Medirom Healthcare Technologies Inc.
What is the Commission File Number for Medirom Healthcare Technologies Inc. as stated in this filing?
The Commission File Number for Medirom Healthcare Technologies Inc. is 001-39809, as indicated on the Form 6-K.
Does the press release furnished as Exhibit 99.1 automatically become 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934?
No, the filing explicitly states that the press release furnished as Exhibit 99.1 shall not be deemed to be 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, unless specifically provided in another filing.
Filing Stats: 273 words · 1 min read · ~1 pages · Grade level 13.6 · Accepted 2024-01-25 16:42:11
Filing Documents
- tmb-20240125x6k.htm (6-K) — 15KB
- tmb-20240125xex99d1.htm (EX-99.1) — 102KB
- tmb-20240125xex99d1001.jpg (GRAPHIC) — 5KB
- tmb-20240125xex99d1003.jpg (GRAPHIC) — 44KB
- tmb-20240125xex99d1004.jpg (GRAPHIC) — 46KB
- tmb-20240125xex99d1005.jpg (GRAPHIC) — 52KB
- tmb-20240125xex99d1006.jpg (GRAPHIC) — 46KB
- tmb-20240125xex99d1007.jpg (GRAPHIC) — 48KB
- tmb-20240125xex99d1008.jpg (GRAPHIC) — 53KB
- tmb-20240125xex99d1009.jpg (GRAPHIC) — 49KB
- 0001558370-24-000548.txt ( ) — 593KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: January 25, 2024 MEDIROM HEALTHCARE TECHNOLOGIES INC. By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer